Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Financings

Dianthus Therapeutics, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Closed: US$288M raised · US$33 a share · Jefferies +4
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Evercore ISI (co-lead), Stifel (co-lead), LifeSci Capital
Use of proceeds: Advance preclinical and clinical development activities, working capital and general corporate purposes
Sep 11, 2025

Read by 6ix AI from the company's releases